Literature DB >> 19767377

Update on the status of 89 drug information centers in the United States.

Jack M Rosenberg1, Sara Schilit, Joseph P Nathan, Tina Zerilli, Howard McGuire.   

Abstract

PURPOSE: Previously identified U.S. drug information centers (DICs) were surveyed to determine whether they were still in existence and whether changes had occurred in the DICs since 2003.
METHODS: Eighty-nine DICs identified in a 2003 survey were surveyed in April 2008. For DICs still in existence, questions were designed to determine whether there were changes in the mission, time spent on activities, staffing, and drug information questions (number, complexity, and time required to answer) compared with five years earlier. Respondents' projected need for their DIC over the next five years was also surveyed.
RESULTS: Seventy-five (84%) of the 89 DICs were still active. The most notable changes in activities were increases in time spent on educating health-professions students (53%), supporting the institution's medication safety program (44%), and providing information-systems support (36%). The majority of respondents (73%) reported no change in the number of employed drug information personnel. The percentages of DICs reporting an increase, decrease, and no change in the number of drug information requests received were 29%, 42%, and 29%, respectively. Seventy percent reported an increase in the number of complex questions, while 53% reported an increase in the time required to answer each question. Ninety-seven percent of respondents projected no change or an increase in the need for their DIC over the next five years.
CONCLUSION: Eighty-four percent of the previously identified DICs were still in existence. The most notable changes in these DICs were increases in the number of DICs focusing on educating health-professions students, the complexity of drug information questions, and the amount of time required to answer each request.

Mesh:

Year:  2009        PMID: 19767377     DOI: 10.2146/ajhp080563

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN: 1079-2082            Impact factor:   2.637


  7 in total

1.  The Evolution of Drug Information Centers and Specialists.

Authors:  Michael P Gabay
Journal:  Hosp Pharm       Date:  2017-08-03

2.  The Evolution of Drug Information Services to Asynchronous Delivery of Pharmacist eConsults.

Authors:  Valerie Clinard; Marilyn Stebbins; Shalini Lynch
Journal:  J Pharm Technol       Date:  2021-10-01

3.  The perceived development needs for medicines information services in university hospital pharmacies: A mixed methods study.

Authors:  Katja Uljas; Katri Hämeen-Anttila; Elina Honkoila; Raisa Laaksonen
Journal:  Explor Res Clin Soc Pharm       Date:  2022-04-25

4.  A question-answer pair (QAP) database integrated with websites to answer complex questions submitted to the Regional Medicines Information and Pharmacovigilance Centres in Norway (RELIS): a descriptive study.

Authors:  Jan Schjøtt; Linda A Reppe; Pål-Didrik H Roland; Tone Westergren
Journal:  BMJ Open       Date:  2012-03-15       Impact factor: 2.692

5.  A two-year utilization of the pharmacist-operated drug information center in Iran.

Authors:  Taher Entezari-Maleki; Mohammad Taraz; Mohammad Reza Javadi; Mir Hamed Hajimiri; Kaveh Eslami; Iman Karimzadeh; Maysam Esmaeili; Kheirollah Gholami
Journal:  J Res Pharm Pract       Date:  2014-10

6.  Factors associated with time consumption when answering drug-related queries to Scandinavian drug information centres: a multi-centre study.

Authors:  Linda Amundstuen Reppe; Olav Spigset; Ylva Böttiger; Hanne Rolighed Christensen; Jens Peter Kampmann; Per Damkier; Stian Lydersen; Jan Schjøtt
Journal:  Eur J Clin Pharmacol       Date:  2014-09-12       Impact factor: 2.953

7.  Use of References in Responses from Scandinavian Drug Information Centres.

Authors:  Jan Schjøtt; Ylva Böttiger; Per Damkier; Linda Amundstuen Reppe; Jens Peter Kampmann; Hanne Rolighed Christensen; Olav Spigset
Journal:  Medicines (Basel)       Date:  2018-07-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.